These results suggest a mechanism through which SETD8 overexpression in endometrial cancer promotes the development of cancer by suppressing the expression of TP73 via H4K20 methylation and p53 methylation, thus inhibiting apoptosis (Figure 6E). The gene discussed is TP53; the disease is endometrial cancer.